IMMUNIC, INC. (IMUX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$9.58M2013: -$31.40M2014: -$50.34M2015: -$52.12M2016: -$41.27M2017: -$52.66M2018: -$12.00M2019: -$37.03M2020: -$48.97M2021: -$91.67M2022: -$119.49M2023: -$99.22M2024: -$98.05M2025: -$103.23M-$103.23M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$103.23M-5.3%
2024-$98.05M+1.2%
2023-$99.22M+17.0%
2022-$119.49M-30.4%
2021-$91.67M-87.2%
2020-$48.97M-32.2%
2019-$37.03M-208.7%
2018-$12.00M+77.2%
2017-$52.66M-27.6%
2016-$41.27M+20.8%
2015-$52.12M-3.5%
2014-$50.34M-60.3%
2013-$31.40M-227.8%
2012-$9.58M